Christoph Garbers

Prof. Dr. Christoph Garbers

Otto von Guericke University of Magdeburg, Magdeburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cytokine
Verified
Journal Article
Closed access
JWJanina Wolf
Janina Wolf
SRStefan Rose-John
Stefan Rose-John
Christoph GarbersChristoph Garbers
Christoph Garbers

1 August 2011 in Trends in Immunology
Verified
Journal Article
Closed access
JSJürgen Scheller
Jürgen Scheller
ACAthena Chalaris
Athena Chalaris
Christoph GarbersChristoph Garbers
Christoph Garbers
SRStefan Rose-John
Stefan Rose-John

28 November 2016 in Nature Immunology
Verified
Journal Article
Open access
PDF file
SHSylvia Heink
Sylvia Heink
NYNir Yogev
Nir Yogev
Christoph GarbersChristoph Garbers
Christoph Garbers
MHMarina Herwerth
Marina Herwerth
LALilian Aly
Lilian Aly
TKThomas Korn
Thomas Korn
Korn and colleagues report that Sirpα+ dendritic cells trans-present the cytokine IL-6 to T cells through a process that requires its receptor IL-6Rα bound to dendritic cells and that trans-presentation is needed to generate pathogenic cells of the TH17 subset of helper T cells in vivo. The cellular sources of interleukin 6 (IL-6) that are relevant for differentiation of the TH17 subset of helper T cells remain unclear. Here we used a novel strategy for the conditional deletion of distinct IL-6-producing cell types to show that dendritic cells (DCs) positive for the signaling regulator Sirpα were essential for the generation of pathogenic TH17 cells. Using their IL-6 receptor α-chain (IL-6Rα), Sirpα+ DCs trans-presented IL-6 to T cells during the process of cognate interaction. While ambient IL-6 was sufficient to suppress the induction of expression of the transcription factor Foxp3 in T cells, trans-presentation of IL-6 by DC-bound IL-6Rα (called 'IL-6 cluster signaling' here) was needed to prevent premature induction of interferon-γ (IFN-γ) expression in T cells and to generate pathogenic TH17 cells in vivo. Our findings should guide therapeutic approaches for the treatment of TH17-cell-mediated autoimmune diseases.

1 June 2012 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
Christoph GarbersChristoph Garbers
Christoph Garbers
HHHeike M. Hermanns
Heike M. Hermanns
FSFred Schaper
Fred Schaper
GMGerhard Müller-Newen
Gerhard Müller-Newen
JGJoachim Grötzinger
Joachim Grötzinger
JSJürgen Scheller
Jürgen Scheller

1 February 2014 in Seminars in Immunology
Verified
Journal Article
Closed access
JSJürgen Scheller
Jürgen Scheller
Christoph GarbersChristoph Garbers
Christoph Garbers
SRStefan Rose-John
Stefan Rose-John

1 June 2011 in European Journal of Cell Biology
Verified
Journal Article
Closed access
ACAthena Chalaris
Athena Chalaris
Christoph GarbersChristoph Garbers
Christoph Garbers
BRBjörn Rabe
Björn Rabe
SRStefan Rose-John
Stefan Rose-John
JSJürgen Scheller
Jürgen Scheller